ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Utilizing combined quantitative multiparametric MRI as potential biomarkers for improved early-stage parkinson's disease diagnosis.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- AGMNet: an explainable gated multimodal framework integrating MRI heterogeneity and dopaminergic asymmetry for Parkinson's disease classification.Frontiers in artificial intelligence · 2026Article
- Sex-related differences among patients with reflex neurally mediated syncope.Internal and emergency medicine · 2025Article
- The combination of theScientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIdentifying Parkinson's disease (PD) during its initial phases presents considerable hurdles for clinicians. PURPOSE: To examine the feasibility and efficacy of a machine learning model based on quantitative multiparametric magnetic resonance imaging (MRI) features in identifying early-stage PD.
methodsWe recruited 33 participants, including 19 with early-stage PD, 14 with advanced-stage PD and 20 healthy control subjects. Each participant underwent both quantitative susceptibility mapping (QSM) and diffusion kurtosis imaging (DKI). We utilized combined QSM and DKI features to establish a support vector machine (SVM) model to identify early-stage PD.
resultsWhen comparing early-stage PD with healthy controls, the SVM model exhibited moderate performance, achieving a training set accuracy of 0.78 and an area under the receiver operating characteristic curve (AUC) of 0.90, and the accuracy of 0.77 (AUC = 0.87) in the test set. When comparing advanced-stage PD with healthy controls, the SVM model exhibited equally high accuracy in both training (0.97, AUC = 0.97) and test (0.94, AUC = 0.94) sets. In discriminating between early-stage PD and advanced-stage PD, the SVM model achieved an accuracy of 0.80 (AUC = 0.81) in the training set and an accuracy of 0.71 (AUC = 0.72) in the test set. The mean kurtosis feature of DKI in the substantia nigra, played a significant role in classification.
conclusionThese findings suggest that early PD is associated with specific MRI features reflecting magnetic susceptibility and microstructural changes. The SVM model combining quantitative QSM and DKI features holds promise for improving early PD diagnosis.
Indexed as
Identifiers
39724321What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.